Sensitization of glycoengineered interferon-β1a-resistant cancer cells by cFLIP inhibition for enhanced anti-cancer therapy

In this study, we examined the molecular mechanism underlying the resistance of cancer cells to R27T, a glycoengineered version of recombinant human interferon (IFN)-β1a, and sought to overcome R27T resistance through combination therapy. R27T has been shown to induce anti-proliferation and apoptosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Tae-Eun, Hong, Sungyoul, Song, Kyoung, Park, Sang-Ho, Shin, Young Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355153/
https://www.ncbi.nlm.nih.gov/pubmed/28086218
http://dx.doi.org/10.18632/oncotarget.14573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355153/
https://www.ncbi.nlm.nih.gov/pubmed/28086218
http://dx.doi.org/10.18632/oncotarget.14573

Ejemplares similares